Crimean-Congo hemorrhagic fever in children
- PMID: 20444644
- PMCID: PMC7108219
- DOI: 10.1016/j.jcv.2010.04.001
Crimean-Congo hemorrhagic fever in children
Abstract
Background: Crimean-Congo hemorrhagic fever (CCHF) virus causes a severe disease in humans with a mortality up to 30%. In Turkey there has been an increase in the number of cases during years since 2002. Humans of all ages living in endemic areas,especially those who are working as shepherds and toddlers, have high risk of acquiring CCHF.
Objectives: The epidemiological, clinical, and laboratory characteristics of the children, who were diagnosed as Crimean-Congo hemorrhagic fever (CCHF) were described.
Study design: The children infected with CCHF virus between April 2008 and October 2009, and hospitalised in Ankara Dişkapi Children's and Research Hospital were included.
Results: Laboratory diagnosis was set by detection of CCHF IgM antibodies and/or genetic detection of CCHF virus. Thirtyone cases included to the study, and all were from the northeastern Anatolia and the southern parts of Black sea region. The mean age was 9.45+/-4.9 years, the proportion of females was 38.7%. The majority (87%) of the cases had the history of tick bite. There was no fatal case. All the patients had the history of fever. Malaise,tonsillopharyngitis, nausea-vomiting, headache, diarrhea, myalgia and rash were the most common symptoms. The mean AST and ALT levels on the admission were 116 (range 25-389) and 61 (range 8-180)U/L respectively. The mean platelet count on admission was 125,000/mm3, and the lowest was 23,000/mm3. The mean of the lowest white blood cell count was 2353/mm3 and the mean of the highest lactate dehydrogenase was 861IU/L.
Conclusions: The clinical course of CCHF among children seems to be milder than in adults. Tonsillopharyngitis is a common symptom among children with CCHF.
Copyright (c) 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Evaluation of cases with a preliminary diagnosis of Crimean- Congo hemorrhagic fever and comparison of characteristics in patients admitted to a secondary care hospital in Kastamonu, Turkey.Afr Health Sci. 2014 Dec;14(4):873-81. doi: 10.4314/ahs.v14i4.15. Afr Health Sci. 2014. PMID: 25834496 Free PMC article.
-
Evaluation of Crimean-Congo hemorrhagic fever suspected cases admitted to a secondary care hospital in Kastamonu, Turkey between 2014-2017.Afr Health Sci. 2019 Mar;19(1):1433-1440. doi: 10.4314/ahs.v19i1.16. Afr Health Sci. 2019. PMID: 31148970 Free PMC article.
-
Evaluation of seroprevalence and clinical and laboratory findings of patients admitted to health institutions in Gümüşhane with suspicion of Crimean-Congo hemorrhagic fever.Turk J Med Sci. 2021 Aug 30;51(4):1825-1832. doi: 10.3906/sag-2001-82. Turk J Med Sci. 2021. PMID: 33754650 Free PMC article.
-
A Comparison of Clinical and Laboratory Features of Crimean-Congo Hemorrhagic Fever in Children and Adults: A Retrospective Single-Center Cohort Study and Literature Review.Vector Borne Zoonotic Dis. 2025 Feb;25(2):81-91. doi: 10.1089/vbz.2024.0066. Epub 2024 Sep 23. Vector Borne Zoonotic Dis. 2025. PMID: 39311706 Review.
-
Crimean-Congo hemorrhagic fever in Turkey: Current status and future challenges.Antiviral Res. 2016 Feb;126:21-34. doi: 10.1016/j.antiviral.2015.12.003. Epub 2015 Dec 13. Antiviral Res. 2016. PMID: 26695860 Review.
Cited by
-
Alterations of serum brain type natriuretic peptide (BNP) in patients with Crimean-Congo hemorrhagic fever.Int J Clin Exp Med. 2015 Feb 15;8(2):2784-8. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 25932235 Free PMC article.
-
Crimean-Congo hemorrhagic fever: an overview.Virol Sin. 2013 Aug;28(4):193-201. doi: 10.1007/s12250-013-3327-4. Epub 2013 Jul 22. Virol Sin. 2013. PMID: 23913177 Free PMC article. Review.
-
Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention.Emerg Infect Dis. 2024 May;30(5):854-863. doi: 10.3201/eid3005.231647. Emerg Infect Dis. 2024. PMID: 38666548 Free PMC article. Review.
-
Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy.J Infect Dis. 2013 Jun 15;207(12):1909-21. doi: 10.1093/infdis/jit061. Epub 2013 Feb 15. J Infect Dis. 2013. PMID: 23417661 Free PMC article.
-
Elevated Human Crimean-Congo Hemorrhagic Fever Virus Seroprevalence in Khashm el Girba, Eastern Sudan.Am J Trop Med Hyg. 2019 Jun;100(6):1549-1551. doi: 10.4269/ajtmh.18-0977. Am J Trop Med Hyg. 2019. PMID: 30994100 Free PMC article.
References
-
- Whitehouse C.A. Crimean-Congo hemorrhagic fever. Antivir Res. 2004;64:145–160. - PubMed
-
- Whitehouse C.A. Risk groups and control measures for Crimean Congo hemorrhagic fever. In: Ergonul O., Whitehouse C.A., editors. Crimean-Congo hemorrhagic fever: a global perspective. Springer; Dordrecht (NL): 2007. pp. 273–280.
-
- Ozkurt Z., Kiki I., Erol S., Erdem F., Yilmaz N., Parlak M. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect. 2006;52:207–215. - PubMed
-
- Ergonul O., Celikbaş A., Dokuzoguz B., Eren S., Baykam N., Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis. 2004;39:284–287. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous